Ulcerative colitis Trials in Great Neck, United States
Conditions / Ulcerative colitis / Great Neck, United States
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
48 total trials for this combination
Showing top 10 of 48 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02118584 | Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies | TERMINATED | PHASE3 |
| NCT03524092 | A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT00505778 | A Comparison of Once a Day Dose Compared to 2 Doses/Day | COMPLETED | PHASE3 |
| NCT03518086 | An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) | COMPLETED | PHASE3 |
| NCT03283085 | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) | COMPLETED | PHASE3 |
| NCT02914522 | Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT02435992 | Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT02100696 | A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors | COMPLETED | PHASE3 |
| NCT00207688 | A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients | COMPLETED | — |
| NCT02914535 | Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE3 |